Other SLC family carriers with a disturbed expression in WD livers were SLC16A1 and SLC22A18. These transporters are mainly engaged in lactate and lipid handling, respectively; therefore, their downregulation in Wilson’s disease may result in disturbances in respective pathways [42, 43]. Here, SLC16A1 is linked to Wilson disease.